Key Facts The European Medicines Agency issued new recommendations Friday, saying patients who take GLP-1 drugs like Ozempic, Wegovy, Mounjaro and Zepbound should inform their doctors ahead of surgery to minimize the risk of adverse respiratory events potentially caused by the drugs
The tablet contains the same active ingredient as the injection (semaglutide) and is the first FDA-approved oral GLP-1 medication for weight loss
The side effects could be extremely serious.
Koite NDL, Sanogo NgI, Lpine O, Bard J-M, Ouguerram K
Introduction Until recently, the worldwide increase in obesity, characterized by a body mass index (BMI) exceeding 30 kg/m 2 , was widely considered an inevitable trend with limited hope for meaningful advances in pharmacological treatment
But above all, it represents a commitment: that each medicine will reach patients exactly as intended protected, effective, and ready to make a difference